日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study

优化晚期肉瘤全身治疗:回顾性单中心研究中吉西他滨、多西他赛、顺铂和依维莫司联合治疗的疗效

Wu, Wen-Chi; Ho, I-Wei; Chen, San-Chi; Chen, Paul Chih-Hsueh; Wu, Po-Kuei; Chen, Chao-Ming; Wu, Hung-Ta; Lin, Chung-Jung; Chao, Ta-Chung; Yen, Chueh-Chuan

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测接受伊马替尼辅助治疗的高危胃肠道间质瘤患者无复发生存期的列线图:一项全国性注册研究

Yeh, Chun-Nan; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Tsai, Hui-Jen

Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma.

铁死亡是去分化脂肪肉瘤中 MDM2 抑制治疗的弱点

Yen Chueh-Chuan, Chen Paul Chih-Hsueh, Chen San-Chi, Wu Wen-Chi, Yen Chiao-Han, Lin Yung-Chan, Wu Po-Kuei, Chen Chao-Ming, Wang Jir-You, Chao Ta-Chung, Yang Muh-Hwa, Fletcher Jonathan A

High-dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma

对患有高危尤文氏肉瘤的儿童和青少年进行大剂量化疗联合自体干细胞移植

Lee, Chih-Ying; Hou, Ming-Hsin; Hung, Giun-Yi; Ho, Cheng-Yin; Yu, Ting-Yen; Wu, Po-Kuei; Chen, Chao-Ming; Yen, Chueh-Chuan; Shiau, Cheng-Ying; Chen, Paul Chih-Hsueh; Wu, Hung-Ta Hondar; Wu, Ching-Lan; Yen, Hsiu-Ju; Chen, Wei-Ming

Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma

转移性前列腺神经内分泌癌治疗结果和基因组学见解的真实世界经验

Lai, Jiun-I; Peng, Yu-Ching; Chang, Peter Mu-Hsin; Chang, Yen-Hwa; Chung, Hsiao-Jen; Huang, Yi-Hsiu; Lin, Tzu-Ping; Huang, William J; Wei, Tzu-Chun; Huang, Tzu-Hao; Yen, Chueh-Chuan

Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

台湾地区接受酪氨酸激酶抑制剂治疗的晚期/复发性胃肠道间质瘤患者的生存情况:一项全国性登记研究

Tsai, Hui-Jen; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Yeh, Chun-Nan

Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)

纳武利尤单抗治疗既往接受过治疗的晚期食管鳞状细胞癌患者的三年随访及疗效-生存关系(ATTRACTION-3)

Okada, Morihito; Kato, Ken; Cho, Byoung Chul; Takahashi, Masanobu; Lin, Chen-Yuan; Chin, Keisho; Kadowaki, Shigenori; Ahn, Myung-Ju; Hamamoto, Yasuo; Doki, Yuichiro; Yen, Chueh-Chuan; Kubota, Yutaro; Kim, Sung-Bae; Hsu, Chih-Hung; Holtved, Eva; Xynos, Ioannis; Matsumura, Yasuhiro; Takazawa, Akira; Kitagawa, Yuko

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience

瑞普替尼在转移性胃肠道间质瘤患者中的同情用药:台湾和香港的经验

Lin, Li-Ching; Huang, Wen-Kuan; Yen, Chueh-Chuan; Yang, Ching-Yao; Sung, Meng-Ta; Wong, Natalie SM; Chua, Daniel T T; Lee, Sarah W M; Chen, Jen-Shi; Yeh, Chun-Nan

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial

多柔比星联合奥拉拉妥单抗与多柔比星联合安慰剂对晚期软组织肉瘤患者生存率的影响:ANNOUNCE随机临床试验

Tap, William D; Wagner, Andrew J; Schöffski, Patrick; Martin-Broto, Javier; Krarup-Hansen, Anders; Ganjoo, Kristen N; Yen, Chueh-Chuan; Abdul Razak, Albiruni R; Spira, Alexander; Kawai, Akira; Le Cesne, Axel; Van Tine, Brian A; Naito, Yoichi; Park, Se Hoon; Fedenko, Alexander; Pápai, Zsuzsanna; Soldatenkova, Victoria; Shahir, Ashwin; Mo, Gary; Wright, Jennifer; Jones, Robin L

Gene amplification and tumor grading in parosteal osteosarcoma

骨旁骨肉瘤的基因扩增和肿瘤分级

Chen, Paul Chih-Hsueh; Yen, Chueh-Chuan; Hung, Giun-Yi; Pan, Chin-Chen; Chen, Wei-Ming